GLUCOTRACK INC (GCTK) Stock Price & Overview
NASDAQ:GCTK • US45824Q8042
Current stock price
The current stock price of GCTK is 0.6646 USD. Today GCTK is up by 2.21%. In the past month the price decreased by -47.67%. In the past year, price decreased by -93.18%.
GCTK Key Statistics
- Market Cap
- 671.246K
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- N/A
- Dividend Yield
- N/A
GCTK Stock Performance
GCTK Stock Chart
GCTK Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to GCTK. When comparing the yearly performance of all stocks, GCTK is a bad performer in the overall market: 99.32% of all stocks are doing better.
GCTK Earnings
GCTK Forecast & Estimates
GCTK Groups
Sector & Classification
GCTK Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
GCTK Ownership
GCTK Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 17.46 | 178.493B | ||
| ISRG | INTUITIVE SURGICAL INC | 44.09 | 161.581B | ||
| SYK | STRYKER CORP | 22.42 | 129.785B | ||
| BSX | BOSTON SCIENTIFIC CORP | 17.67 | 90.933B | ||
| IDXX | IDEXX LABORATORIES INC | 37.98 | 46.558B | ||
| EW | EDWARDS LIFESCIENCES CORP | 25.84 | 45.97B | ||
| BDX | BECTON DICKINSON AND CO | 11.31 | 44.266B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 14.16 | 33.229B | ||
| RMD | RESMED INC | 18.64 | 33.212B | ||
| DXCM | DEXCOM INC | 25.18 | 25.278B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.98 | 18.201B | ||
| HOLX | HOLOGIC INC | 15.48 | 16.969B | ||
| PODD | INSULET CORP | 30.46 | 14.039B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About GCTK
Company Profile
GlucoTrack, Inc. designs, develops, and commercializes non-invasive glucose monitoring devices for use by persons suffering from diabetes. The company is headquartered in Rutherford, New Jersey and currently employs 11 full-time employees. The company went IPO on 2013-04-09. The firm is engaged in developing a long-term Implantable Continuous Blood Glucose Monitor (CBGM) for people living with Type 1 diabetes and insulin-dependent Type 2 diabetes. Its CBGM is a long-term, implantable system that continually measures blood glucose levels with a sensor longevity of 3 years, no on-body wearable component and with minimal calibration. Its CBGM technology allows for a less burdensome approach to glucose monitoring. The company has also completed four animal studies with evolving prototype systems, all four of which consistently demonstrated a simple implant procedure, functionality, and safety. The firm has also demonstrated continuous glucose sensing in the epidural space via two additional animal trials, both of which demonstrated a simple implant procedure, functionality, and safety.
Company Info
IPO: 2013-04-09
GLUCOTRACK INC
301 Rt 17 North, Suite 800
Rutherford NEW JERSEY US
Employees: 11
Phone: 197286757878
GLUCOTRACK INC / GCTK FAQ
What does GLUCOTRACK INC do?
GlucoTrack, Inc. designs, develops, and commercializes non-invasive glucose monitoring devices for use by persons suffering from diabetes. The company is headquartered in Rutherford, New Jersey and currently employs 11 full-time employees. The company went IPO on 2013-04-09. The firm is engaged in developing a long-term Implantable Continuous Blood Glucose Monitor (CBGM) for people living with Type 1 diabetes and insulin-dependent Type 2 diabetes. Its CBGM is a long-term, implantable system that continually measures blood glucose levels with a sensor longevity of 3 years, no on-body wearable component and with minimal calibration. Its CBGM technology allows for a less burdensome approach to glucose monitoring. The company has also completed four animal studies with evolving prototype systems, all four of which consistently demonstrated a simple implant procedure, functionality, and safety. The firm has also demonstrated continuous glucose sensing in the epidural space via two additional animal trials, both of which demonstrated a simple implant procedure, functionality, and safety.
What is the current price of GCTK stock?
The current stock price of GCTK is 0.6646 USD. The price increased by 2.21% in the last trading session.
Does GLUCOTRACK INC pay dividends?
GCTK does not pay a dividend.
What is the ChartMill rating of GLUCOTRACK INC stock?
GCTK has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
Can you provide the ownership details for GCTK stock?
You can find the ownership structure of GLUCOTRACK INC (GCTK) on the Ownership tab.